昭衍新药

- 603127

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
昭衍新药(603127) 利润表
单位:万元
报表日期2023-12-312023-09-302023-06-302023-03-312022-12-31
一、营业总收入237,648.68158,707.98101,207.7336,938.60226,797.10
营业收入237,648.68158,707.98101,207.7336,938.60226,797.10
二、营业总成本162,201.02110,483.7271,419.6626,281.13141,876.56
营业成本136,370.1189,245.5656,350.9717,843.00118,165.95
营业税金及附加767.61574.08330.04166.51920.69
销售费用2,461.511,833.261,186.61536.121,800.75
管理费用28,025.4822,923.6815,249.297,454.3828,658.85
财务费用-15,109.12-11,856.83-7,390.60-2,480.03-15,468.16
研发费用9,685.447,763.975,693.342,761.167,798.47
资产减值损失----------
公允价值变动收益-24,564.15-10,851.39-19,767.099,844.1634,956.75
投资收益962.78714.17584.3551.411,302.24
其中:对联营企业和合营企业的投资收益-306.92-255.31-167.90-76.99-269.09
汇兑收益----------
三、营业利润50,709.6339,208.4911,683.9121,436.97122,563.89
加:营业外收入38.6723.5922.192.141,464.48
减:营业外支出53.2633.5712.546.2128.13
其中:非流动资产处置损失----------
四、利润总额50,695.0439,198.5211,693.5721,432.89124,000.23
减:所得税费用11,539.796,578.822,742.752,661.8816,680.22
五、净利润39,155.2632,619.708,950.8218,771.01107,320.01
归属于母公司所有者的净利润39,699.2632,759.849,062.7218,775.97107,425.72
少数股东损益-544.00-140.14-111.90-4.96-105.71
六、每股收益
基本每股收益(元/股)0.53000.44000.17000.35002.0100
稀释每股收益(元/股)0.53000.44000.17000.35002.0000
七、其他综合收益496.081,018.421,325.21-440.266,881.41
八、综合收益总额39,651.3333,638.1210,276.0318,330.74114,201.42
归属于母公司所有者的综合收益总额40,195.3333,778.2610,387.9318,335.70114,307.13
归属于少数股东的综合收益总额-544.00-140.14-111.90-4.96-105.71
下载全部历史数据到excel中 返回页顶